Egetis Therapeutics

Declaration of Voting Results & Voting Rights Announcements • Apr 15, 2021

Issuer Egetis Therapeutics AB (publ)

Holder

Skandinaviska Enskilda Banken AB

Instrument

Instrument	Common stocks SE0003815604
Before the transaction
Shares	9,755,483
Voting rights	9,755,483
Transaction
Reason for major shareholding notification Sell
Date	13/04/2021
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	7,975,125
Directly held voting rights	0
Indirectly held voting rights	7,975,125
Percentage
Directly held shares	4.8314 %
Directly held voting rights	0 %
Indirectly held voting rights	4.8314 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	4.8314 %	7,975,125
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	4.8314 %	7,975,125

Chain of controlling companies

	Voting rights % Voting rights Company
582,688	0.353	Gamla Livförsäkringsaktiebolaget SEB Trygg Liv
7,392,437 4.4784		SEB Life International Assurance Company Ltd
Group total holdings
Voting rights		7,975,125
	Percentage of voting rights 4.8314

Published

15/04/2021 10:57

Contact

Name	Inga Brutane
Phone	+46 8 522 296 10 Email GroupComplianceControlRoom@seb.se

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25